Retour
Fourchette du Jour
3,00 €
3,00 €
Fourchette 52 Semaines
1,97 €
4,23 €
Volume
1 000
Moyenne 50J / 200J
3,00 €
/
2,99 €
Clôture Précédente
3,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -5,1 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | -14,3 | 3,7 |
| Net Margin % | -35,0 | 3,9 |
| Rev Growth 5Y % | -11,8 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
-0,12 €
-0,13 € – -0,12 €
|
5,2 B | 1 |
| FY2027 |
-0,22 €
-0,23 € – -0,21 €
|
4,1 B | 1 |
| FY2026 |
-0,52 €
-0,54 € – -0,50 €
|
3,3 B | 1 |
Points Clés
Revenue declined -11,82% annually over 5 years
Negative free cash flow of -1,21B
PEG of 0,72 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 36,75%
Capital intensive — 30,75% of revenue goes to capex
Croissance
Revenue Growth (5Y)
-11,82%
Revenue (1Y)24,93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-14,30%
ROIC-6,70%
Net Margin-35,00%
Op. Margin-37,37%
Sécurité
Debt / Equity
0,69
Current Ratio1,60
Interest Coverage-12,37
Valorisation
P/E Ratio
-5,09
P/B Ratio0,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24,93% | Revenue Growth (3Y) | 27,27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -11,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,43B | Net Income (TTM) | -851,83M |
| ROE | -14,30% | ROA | -6,88% |
| Gross Margin | 72,34% | Operating Margin | -37,37% |
| Net Margin | -35,00% | Free Cash Flow (TTM) | -1,21B |
| ROIC | -6,70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,69 | Current Ratio | 1,60 |
| Interest Coverage | -12,37 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -5,09 | P/B Ratio | 0,72 |
| P/S Ratio | 1,78 | PEG Ratio | 0,72 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,34B | Enterprise Value | 5,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,43B | 1,95B | 1,50B | 1,45B | 4,02B |
| Net Income | -851,83M | -1,28B | -2,28B | -2,39B | -718,56M |
| EPS (Diluted) | -0,84 | -1,30 | -2,32 | -2,60 | -0,81 |
| Gross Profit | 1,76B | 1,45B | 835,26M | 927,21M | 2,77B |
| Operating Income | -909,47M | -1,30B | -2,45B | -2,75B | -592,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,39B | 10,80B | 11,36B | 12,56B | 11,05B |
| Total Liabilities | 6,16B | 4,85B | 4,02B | 2,78B | 2,72B |
| Shareholders' Equity | 6,03B | 5,88B | 7,17B | 9,48B | 7,96B |
| Total Debt | 4,14B | 2,93B | 1,79B | 1,32B | 628,20M |
| Cash & Equivalents | 2,62B | 2,49B | 3,78B | 6,00B | 3,50B |
| Current Assets | 4,46B | 4,28B | 5,55B | 7,22B | 5,83B |
| Current Liabilities | 2,78B | 2,53B | 2,48B | 1,77B | 2,02B |